KRT19 and adenocarcinoma: As shown in Supplementary Fig. S2b, xenograft tumors derived from IHCC organoids after hepatocyte differentiation were CK19-positive adenocarcinomas with glandular and tubular structures, being compatible with IHCC, and not HCC.